Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of telaprevir in subjects with hepatic impairment

Trial Profile

Study of telaprevir in subjects with hepatic impairment

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Oct 2008

At a glance

  • Drugs Telaprevir (Primary)
  • Indications Hepatitis C
  • Focus Pharmacokinetics
  • Sponsors Vertex Pharmaceuticals
  • Most Recent Events

    • 28 Oct 2008 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
    • 28 Oct 2008 Actual start date (Sep 2007) added as reported by ClinicalTrials.gov.
    • 28 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top